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Author's reply:
Sir, We thank Dr Dodd for his interest in our paper. Infections in total knee replacement (TKR) are rare and depend on many factors, and one would need a very large study to demonstrate conclusively the connection between steroids and an increased risk of post-TKR infection. Our study though, demonstrates sufficient concern and concludes that the decision to administer intra-articular steroids to a patient who may be a candidate for knee replacement surgery should not be taken lightly.
Many centres should review their results retrospectively and report them. The variable time and number between steroid injection and time to surgery is one of the inherent limitations of any retrospective study. The important fact is that there seems to be an increased risk of infection in patients who have had a steroid injection in the 11-month period prior to TKR. This is of increased importance since the waiting list for a joint replacement in the United Kingdom is currently about six months. I believe that there is enough published data [1] [2] [3] [4] [5] [6] to show that intraarticular steroid injections show a positive effect that is only short-lived (1 to 4 weeks), and is confounded by a powerful response to placebo, and as such are of limited benefit in the long-term management of osteoarthritis (OA) of the knee.
I agree that clinical experience shows that few patients achieve a significant and sustained response. The problem is that it is not possible to predict which patients will actually respond. 7 Osteoarthritis is increasingly viewed as a phasic condition in which organ damage occurs intermittently. The ability to detect these phases of increased disease activity perhaps could in the future lead to a more rational approach to the use of intraarticular steroids in OA. In our unit we avoid intra-articular steroids in patients that are to be placed on the waiting list for TKR. If a patient is not a candidate for TKR and has had a good and lasting response to intra-articular steroid treatment in the past then the injection is repeated. Sir, I read with interest the paper by Papavasiliou et al 1 in the March 2006 issue entitled "Infection in knee replacements after previous injection of intra-articular steroid". Many surgeons anecdotally feel that injecting knees with steroid prior to total knee replacement is not advisable. It was interesting to note that the authors did not find any relationship between the number, or timing of, injections and post-operative deep infection. I would like to raise the following queries with the authors.
1. It has been mentioned that the steroid is 'reactivated' in the knee several months after injection. What exactly do they mean by that?
2. From personal experience, I know that many surgeons in North America inject a cocktail of drugs into wounds after total hip and knee replacements, often containing, among others, a long-lasting steroid. The authors quote no increase in post-operative infection rates. Author's reply:
Sir, We thank Mr Vashista for his comments.
1. The length of time between injection of steroids into the knee and subsequent increased risk of post-operative infection lead us to speculate that some of the steroid crystals do not fully dissolve within the knee joint but remain within the surrounding soft tissues or cystic areas of degeneration within the knee. Jones et al, 1 in a contrast radiography study, reported that one third of injections into the knee are actually extra-articular and within the surrounding soft tissues. At the time of the operation the steroid crystals may be released (reactivated) from the soft tissues finding their way into the operating field.
2. I am not aware of such a practice. I do know that US surgeons inject a cocktail of drugs into knee joint replacements, but for analgesia and haemostasis purposes. 
